1alpha,24S-Dihydroxyvitamin D2

DB06117ExperimentalSmall molecule

LR-103 is a naturally occurring D-hormone that is produced by the kidneys from vitamin D. LR-103 is one of the D-hormones produced from Hectorol. It is developed for the treatment... It is developed for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD).

Primary indication: Investigated for use/treatment in parathyroid disorders.Curator reviewed
Formula / weight: C₂₈H₄₄O₃ · 428.657 g/mol (avg)
Code names: LR-103

Resolves to

Compound

UNII2900I92Z36CAS156316-85-7

Clinical / RWD

RxNorm1536458

Structure

InChIKeyODZFJAXAEXQSKL-WRJREGAQSA-NSMILESCC(C)[C@](C)(O)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C

What you can answer from here — as of March 06, 2025

156Drug interactionsStructured to mechanism, not free text

Which companies are running trials of 1alpha,24S-Dihydroxyvitamin D2, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account